# Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis

> **NCT04380220** · — · UNKNOWN · sponsor: **Regina Elena Cancer Institute** · enrollment: 80 (actual)

## Conditions studied

- Multiple Sclerosis
- Relapse

## Interventions

- **DIAGNOSTIC_TEST:** Blood samples and processing

## Key facts

- **NCT ID:** NCT04380220
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-07
- **Primary completion:** 2020-08-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-05-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380220

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380220, "Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT04380220. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*